These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28608305)

  • 1. Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run.
    Versteijne E; Lens E; van der Horst A; Bel A; Visser J; Punt CJA; Suker M; van Eijck CHJ; van Tienhoven G
    Strahlenther Onkol; 2017 Aug; 193(8):630-638. PubMed ID: 28608305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.
    Versteijne E; van Eijck CH; Punt CJ; Suker M; Zwinderman AH; Dohmen MA; Groothuis KB; Busch OR; Besselink MG; de Hingh IH; Ten Tije AJ; Patijn GA; Bonsing BA; de Vos-Geelen J; Klaase JM; Festen S; Boerma D; Erdmann JI; Molenaar IQ; van der Harst E; van der Kolk MB; Rasch CR; van Tienhoven G;
    Trials; 2016 Mar; 17(1):127. PubMed ID: 26955809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
    Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
    Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
    Okamoto H; Murakami N; Isohashi F; Kasamatsu T; Hasumi Y; Iijima K; Nishioka S; Nakamura S; Nakamura M; Nishio T; Igaki H; Nakayama Y; Itami J; Ishikura S; Nishimura Y; Toita T
    Radiat Oncol; 2019 Jul; 14(1):133. PubMed ID: 31358026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance for a multicenter Phase II study of stereotactic ablative radiotherapy for hepatocellular carcinoma ≤5 cm: a planning dummy run.
    Bae SH; Kim MS; Jang WI; Kim KB; Cho KH; Kim WC; Lee CY; Kim ES; Choi CW; Chang AR; Jo S; Kim JY
    Jpn J Clin Oncol; 2017 Jun; 47(6):535-542. PubMed ID: 28419246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
    Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.
    Huguet F; Goodman KA; Azria D; Racadot S; Abrams RA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1355-64. PubMed ID: 22768988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy-run.
    Widder J; Sedlmayer F; Stanek C; Pötter R
    Radiother Oncol; 2000 Sep; 56(3):341-7. PubMed ID: 10974384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer planning: Complex conformal vs modulated therapies.
    Chapman KL; Witek ME; Chen H; Showalter TN; Bar-Ad V; Harrison AS
    Med Dosim; 2016; 41(2):100-4. PubMed ID: 26831922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application.
    Qi XS; Ruan D; Lee SP; Pham A; Kupelian P; Low DA; Steinberg M; Demarco J
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):817-24. PubMed ID: 25752396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre quality assurance of intensity-modulated radiation therapy plans: a precursor to clinical trials.
    Williams MJ; Bailey M; Forstner D; Metcalfe PE
    Australas Radiol; 2007 Oct; 51(5):472-9. PubMed ID: 17803801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.
    Li G; Wu K; Peng G; Zhang Y; Bai S
    Med Dosim; 2014; 39(4):309-13. PubMed ID: 24958705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
    Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
    Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
    Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
    Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-related quality assurance with different combinations of treatment planning systems, techniques, and machines : A multi-institutional survey.
    Steiniger B; Berger R; Eilzer S; Kornhuber C; Lorenz K; Peil T; Reiffenstuhl C; Schilz J; Schröder D; Schwedas M; Pensold S; Walke M; Weibert K; Wolf U; Wiezorek T
    Strahlenther Onkol; 2017 Jan; 193(1):46-54. PubMed ID: 27812732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: the dummy run.
    Valley JF; Bernier J; Tercier PA; Fogliata-Cozzi A; Rosset A; Garavaglia G; Mirimanoff RO
    Radiother Oncol; 1998 Apr; 47(1):37-44. PubMed ID: 9632290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of dose prescription and compliance to international standard (ICRU-83) in intensity modulated radiation therapy among academic institutions.
    Das IJ; Andersen A; Chen ZJ; Dimofte A; Glatstein E; Hoisak J; Huang L; Langer MP; Lee C; Pacella M; Popple RA; Rice R; Smilowitz J; Sponseller P; Zhu T
    Pract Radiat Oncol; 2017; 7(2):e145-e155. PubMed ID: 28274405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance for the EORTC 22071-26071 study: dummy run prospective analysis.
    Fairchild A; Langendijk JA; Nuyts S; Scrase C; Tomsej M; Schuring D; Gulyban A; Ghosh S; Weber DC; Budach W
    Radiat Oncol; 2014 Nov; 9():248. PubMed ID: 25424399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.